M&A - Page 1 | TalkMarkets
All Posts > Content under M&A
1 to 16 of 1278 Posts
1 2 3 ... 80
The Pool Of Publicly Traded Stocks Is Shrinking. Here's What Investors Can Do
Article By: Frank Holmes
Monday, August 13, 2018 6:22 PM EDT
More companies have delisted, than gone public in every year of the past 20 years except one, 2013. The pool is getting smaller even while the population and economy are expanding.
Week In Review: Shanghai Junshi Biosciences Files For $500 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, August 11, 2018 7:27 PM EDT
Shanghai Junshi Biosciences has filed for a Hong Kong IPO that is expected to raise up to $500 million. Junshi is developing a pipeline of 13 biologic drugs, including immuno-oncology treatments.
In this article: SGYP, CELG, GILD, CANF, BGNE
Barclays Sees Upside For Cigna Even With No Deal As Icahn Opposes Merger
Article By: The Fly
Tuesday, August 7, 2018 12:32 PM EDT
If the deal is approved, the analyst sees Cigna shares falling to $180 in the near-term.
In this article: CI, ESRX Also: AMZN, ANTM
Street Fight: BWS Says Sell GTT As William Blair Remains Bullish
Article By: The Fly
Monday, August 6, 2018 12:06 PM EDT
In morning trading, shares of GTT have dropped almost 2% to $39.75.
In this article: GTT
ServiceNow Expands Its AI Portfolio
Article By: Sramana Mitra
Monday, August 6, 2018 11:29 AM EDT
ServiceNow recently reported a strong second quarter that beat estimates.
In this article: NOW
Week In Review: Two Hong Kong IPOs - BeiGene And Ascletis - Raise A Combined $1.3 Billion
Article By: ChinaBio® Today
Saturday, August 4, 2018 4:27 PM EDT
BeiGene, a Beijing oncology company, raised $900 million in a debut offering on the Hong Kong stock exchange. Ascletis Pharma of Hangzhou completed a $400 million IPO on the Hong Kong exchange at a $2 billion capitalization
In this article: AMGN, BGNE
Cigna Investor Carl Icahn Plans To Vote Against Express Scripts Deal, WSJ Says
Article By: The Fly
Thursday, August 2, 2018 6:17 AM EDT
According to a WSJ report, activist investor Carl Icahn, who has built a sizable stake in Cigna (CI), is planning to vote against the company's planned $54B acquisition of Express Scripts (ESRX).
In this article: CI, ESRX, AMZN
Week In Review: Long Hill Capital Closes $265 Million Fund For China Healthcare
Article By: ChinaBio® Today
Saturday, July 28, 2018 4:14 PM EDT
Long Hill Capital of Beijing and Shanghai, focused the healthcare and consumer sectors, closed its second fund at $265 million. Long Hill said it "significantly exceeded” its funding target, showing the success of its thesis-investing strategy.
In this article: BMY, MRK, SNY, CELG, BGNE
AT&T's Business Is Shrinking Not Growing, Say Analysts
Video By: CNBC
Tuesday, July 24, 2018 8:05 PM EDT
AT&T misses its revenues in its quarterly earnings report.
In this video: T
Synovus To Acquire FCB Financial For $2.9B
Article By: The Fly
Tuesday, July 24, 2018 12:05 PM EDT
Synovus expects approximately $40 million in pretax synergies to be fully realized by 2020.
In this article: SNV, FCB
M&A Hits Record In 1H: Ride High With These ETFs
Article By: Sweta Killa
Saturday, July 21, 2018 5:13 PM EDT
Merger and acquisition activities across the globe hit record highs in the first half of 2018 driven by growing ambition of American companies. We have highlighted three merger ETFs to ride out the surge from the increasing M&A deals.
In this article: CI, T, TWX, ESRX, FOXA, COL, MNA, ANDV, MRGR
Week In Review: Acletis Raising $457 Million In Hong Kong IPO At $2 Billion Valuation
Article By: ChinaBio® Today
Saturday, July 21, 2018 4:12 PM EDT
Ascletis BioScience, the Hangzhou biopharma with a novel treatment for hepatitis C, may raise as much as $457 million in its upcoming Hong Kong IPO, a debut offering that values the company at $2 billion.
In this article: MESO
Apollo, Other PE Firms Express Interest In Arconic
Article By: The Fly
Saturday, July 14, 2018 7:15 PM EDT
Arconic has received takeover interest from private-equity firms, including Apollo Global Management, the Wall Street Journal reports, citing people familiar with the matter.
In this article: APO, ARNC
Week In Review: Tasly Biopharma Completes Pre-IPO Round At $1.9 Billion Valuation
Article By: ChinaBio® Today
Saturday, July 14, 2018 4:49 PM EDT
Tasly Biopharma (SHA: 600535) of Shanghai raised $84.5 million in new capital from a group of investors that included Ally Bridge. The funding is a pre-IPO round as Tasly is planning to list on the Hong Kong Exchange.
In this article: MRK, NVS, IBIO
Justice Department Defies Judge To Appeal AT&T-Time Warner Merger Approval
Article By: Tyler Durden
Thursday, July 12, 2018 7:29 PM EDT
The news sent shares of AT&T lower just under 2% in the after-market, to a 3-week low.
In this article: T Also: X, TWX
21st Century Fox Boosts Offer For Sky To GBP 14 Or $32.5B
Article By: The Fly
Wednesday, July 11, 2018 6:40 AM EDT
21st Century Fox and the Independent Committee of Sky PLC announced that they have reached agreement on an increased recommended pre-conditional cash offer for the fully diluted share capital of Sky.
In this article: FOXA, SKYAY Also: DIS, CMCSA
1 to 16 of 1278 Posts
1 2 3 ... 80